OTCMKTS:ESALY Eisai (ESALY) Stock Price, News & Analysis $61.51 -1.33 (-2.11%) As of 01/30/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Eisai Stock (OTCMKTS:ESALY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Eisai alerts:Sign Up Key Stats Today's Range$61.00▼$63.2950-Day Range$61.51▼$61.5152-Week Range$36.88▼$73.90Volume331,800 shsAverage Volume60,916 shsMarket Capitalization$17.64 billionP/E Ratio70.70Dividend Yield1.43%Price TargetN/AConsensus RatingN/A Company OverviewEisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.Read More… Remove Ads Receive ESALY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter. Email Address ESALY Stock News HeadlinesEcoNaviSta, Inc. Supports Eisai Co., Ltd.’s Tender OfferMarch 14, 2025 | tipranks.comEisai stock price target cut to JPY5,000 at Citi, retains Buy ratingFebruary 10, 2025 | msn.comAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.April 5, 2025 | Paradigm Press (Ad)Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in EuropeOctober 14, 2024 | finance.yahoo.comAlzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatmentSeptember 8, 2024 | cnbc.comThis matcha set helped me break my coffee addiction and I’ve never looked backSeptember 2, 2024 | msn.comEisai Co., Ltd. (ESAIY)July 27, 2024 | finance.yahoo.comBiogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side EventsJuly 26, 2024 | msn.comSee More Headlines ESALY Stock Analysis - Frequently Asked Questions How have ESALY shares performed this year? Eisai's stock was trading at $61.51 on January 1st, 2025. Since then, ESALY stock has increased by 0.0% and is now trading at $61.51. View the best growth stocks for 2025 here. How were Eisai's earnings last quarter? Eisai Co., Ltd. (OTCMKTS:ESALY) posted its quarterly earnings results on Wednesday, August, 4th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.25. The company had revenue of $1.82 billion for the quarter. Eisai had a net margin of 4.11% and a trailing twelve-month return on equity of 3.86%. How do I buy shares of Eisai? Shares of ESALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/04/2021Today4/05/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryPersonal Services Current SymbolOTCMKTS:ESALY CIK948406 Webwww.eisai.co.jp Phone(133) 817-3700Fax813-3811-6032Employees11,322Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.87 Trailing P/E Ratio70.70 Forward P/E Ratio32.37 P/E Growth2.46Net Income$426.79 million Net Margins4.11% Pretax MarginN/A Return on Equity3.86% Return on Assets2.50% Debt Debt-to-Equity Ratio0.10 Current Ratio2.20 Quick Ratio1.77 Sales & Book Value Annual Sales$6.74 billion Price / Sales2.62 Cash Flow$2.68 per share Price / Cash Flow22.94 Book Value$23.94 per share Price / Book2.57Miscellaneous Outstanding Shares286,770,000Free FloatN/AMarket Cap$17.64 billion OptionableNot Optionable Beta0.31 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:ESALY) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eisai Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eisai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.